Oncolytic vaccinia virus such as JX-594 lacks the TK gene and expresses granulocyte-macrophage colony-stimulating factor (GM-CSF), specifically targets liver cancer cells with high cellular TK activity and activated EGFR signaling, which facilitates its replication [98]. This evidence concerns the gene TKT and liver cancer.